EP3356386
METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.9.2016EP published:
14.2.2024EP application number:
16782150.3
EP translation filed:
10.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
28.9.2036Expiry date:
28.9.2026Next due date:
30.9.2026
Title in English:
METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERSLanguage of the patent:
English
Timeline
Today
29.9.2016EP application
14.2.2024EP Publication
10.5.2024Translation submitted
15.6.2024Registration published
28.9.2026Expires
Owner
Name:
Rhythm Pharmaceuticals, Inc.Address:
222 Berkeley Street, 12th floor, Boston, MA 02116, US
Inventor
Name:
SHARMA, ShubhAddress:
Cranbury, NJ 08512, US
Name:
VAN DER PLOEG, Leonardus H.T.Address:
Newton, MA 02467, US
Name:
HENDERSON, BartAddress:
Belmont, MA 02478, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201562235003 PDate:
30.9.2015Country:
US
Classification
Categories:
C07K 7/06, A61P 3/04, A61P 3/10, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 17.9.2024
Expires: 28.9.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.9.2025
Expires: 28.9.2026
Payer: Árnason Faktor ehf.